Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK removes zinc from denture cream

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline says it will remove zinc from its denture creams, including Super PoliGrip Original, Ultra Fresh and Extra Care, as a "voluntary, precautionary action" in response to potential health risks related to "long-term, excessive" use of the mineral. The consumer warning and reformulation come after the company received around 400 reports of neurological symptoms associated with the products between 1996 and 2009. According to a Feb. 19 press release from the Great Neck, N.Y.-based firm Parker Waichman Alonso, lawyers representing clients in a class action lawsuit against Glaxo for allegedly failing to warn consumers of the risk applaud the change and urge the firm to recall the products "given their devastating impact on consumers," (1"The Tan Sheet" Oct. 9, 2009). The law firm also urged Procter & Gamble to remove zinc from its denture cream Fixodent. P&G did not return a call prior to deadline. Both firms assure consumers that the creams are safe when used as directed

You may also be interested in...



Glaxo Promotes Reformulated Poligrip With Focus On Comfort, Confidence

With the number of denture-wearers increasing, GlaxoSmithKline launches its Super Poligrip denture cream line reformulated without zinc, an adhesive ingredient that has drawn lawsuits and negative press

Zinc Lawsuits, Recalls May Taint Mineral's Image

Lawsuits alleging that zinc in two popular denture creams damages nerves, combined with the recent recall of some zinc-containing Zicam products, could call into question the use of the mineral, which trade groups insist is safe when taken appropriately

Big Pharma BD Execs Tell Start-Ups: Don’t Be Afraid To Ask Us For Help

Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.

Topics

UsernamePublicRestriction

Register

PS103818

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel